2026 CCC | A Phase 1 and Randomized Phase 2 Trial of Selinexor and Temozolomide in Recurrent Glioblastoma
0% Complete
Course Content
This material is non-CME, no credits are available, and a certificate will not be provided upon completion.
Course Details
- Duration
- 0.00 hour
- Released
- Aug 28, 2026
- Last Review
- Aug 28, 2026
- Expires
- Aug 28, 2029
Target Audience
Physicians
Nurses
Pharmacists
Physician Associates
Accreditation
N/A
